As of July 2025 DBV Technologies has a market cap of C$0.37 Billion. This makes DBV Technologies the world's 8077th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$0.37 B | 271.24% |
2024 | C$0.10 B | -60.7% |
2023 | C$0.25 B | -33.96% |
2022 | C$0.39 B | 60.89% |
2021 | C$0.24 B | -34.95% |
2020 | C$0.37 B | -72.4% |
2019 | C$1.35 B | 171.25% |
2018 | C$0.49 B | -68.3% |
2017 | C$1.57 B | -31.16% |
2016 | C$2.28 B | -6.44% |
2015 | C$2.43 B | 105.07% |
2014 | C$1.18 B |
On Jul 28th, 2025 the market cap of DBV Technologies was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Ionis Pharmaceuticals
IONS | C$9.00 B | 2,294.30% | ๐บ๐ธ USA |
![]() Flexion Therapeutics
FLXN | C$0.63 B | 67.69% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | C$58.17 B | 15,374.16% | ๐บ๐ธ USA |